Krsnaa Diagnostics Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Krsnaa Diagnostics Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹108Over the last 3 years, every ₹100 of reported profit came with ₹108 of operating cash.
Higher than 50% of Healthcare companies in India.
Self-Funding Ratio
0.5×Over the last 3 years its own operating cash paid for 47% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 82% of Healthcare companies in India.
Cash Locked Ratio
₹16For every ₹100 of sales, ₹16 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹2 tied up three years earlier.
Less money tied up than 66% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹14Sales grew 59% in 3 years; of every extra ₹100 of sales, ₹14 became extra profit.
Lower than 60% of Healthcare companies in India.
Asset Productivity Ratio
+59% / +100%In 3 years sales changed by +59% while total assets changed by +100%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
2.7×Debt due within a year is covered 2.7 times by its yearly operating cash.
Higher than 63% of Healthcare companies in India.
Cash Cushion Ratio
−10%Debt, after subtracting cash, equals 10% of its market value (net debt).
Lower than 79% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 72% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 71% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Krsnaa Diagnostics Limited owes ₹0.46 for every ₹1 it owns. Net profit rose 31% in the year to Mar 2026, and grew 18% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
16.8Investors pay ₹16.8 for every ₹1 of Krsnaa Diagnostics Limited's yearly profit, lower than 88% of Healthcare companies in India.
P/B ratio
1.65The share price is 1.65 times Krsnaa Diagnostics Limited's book value per share, lower than 91% of Healthcare companies in India.
Market cap
₹1,617 CrThe total market value of all of Krsnaa Diagnostics Limited's shares at today's price (share price × number of shares), smaller than 71% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹980 CrWhat Krsnaa Diagnostics Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹302.23Net worth divided by the number of shares. The share price of ₹498.40 is 1.6 times this, which is the P/B above.
Return on equity (ROE)
9.8%Krsnaa Diagnostics Limited earned 9.8% on its shareholders' money over the last year, lower than 68% of Healthcare companies in India.
Owes vs Owns
0.46×Krsnaa Diagnostics Limited owes ₹0.46 for every ₹1 it owns (low), higher than 76% of Healthcare companies in India.
Dividend yield
0.37%Krsnaa Diagnostics Limited pays 0.37% of its share price as dividends a year, lower than 51% of dividend-paying Healthcare companies in India.
Revenue growth
+8%Revenue rose 8% in the year to Mar 2026, and grew 17% a year on average over 3 years.
Profit growth
+31%Net profit rose 31% in the year to Mar 2026, and grew 18% a year on average over 3 years.
Profit margin
13.1%Krsnaa Diagnostics Limited keeps ₹13 of every ₹100 of revenue as net profit.
Cash quality
1.4×Cash from Krsnaa Diagnostics Limited's business was 1.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
3.8×Krsnaa Diagnostics Limited's operating profit covered its interest costs 3.8 times in the year to Mar 2026.
Cash vs debt
Net debtKrsnaa Diagnostics Limited had ₹174 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Krsnaa Diagnostics Limited's P/E ratio?
Investors pay ₹16.8 for every ₹1 of Krsnaa Diagnostics Limited's yearly profit, lower than 88% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Krsnaa Diagnostics Limited: ₹1,617 Cr ÷ ₹980 Cr (31 Mar 2026) = 1.6.
What is Krsnaa Diagnostics Limited's return on equity?
Krsnaa Diagnostics Limited earned 9.8% on its shareholders' money over the last year, lower than 68% of Healthcare companies in India.
How much does Krsnaa Diagnostics Limited owe compared with what it owns?
Krsnaa Diagnostics Limited owes ₹0.46 for every ₹1 it owns (low), higher than 76% of Healthcare companies in India.
Does Krsnaa Diagnostics Limited pay a dividend?
Yes. Krsnaa Diagnostics Limited pays 0.37% of its share price as dividends a year, lower than 51% of dividend-paying Healthcare companies in India.
Is Krsnaa Diagnostics Limited's revenue growing?
Revenue rose 8% in the year to Mar 2026, and grew 17% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.